Provision of antiretroviral therapy to children within the public sector of South Africa.

[1]  J. Overbaugh,et al.  Early Response to Highly Active Antiretroviral Therapy in HIV-1-Infected Kenyan Children , 2007, Journal of acquired immune deficiency syndromes.

[2]  Sarah C Leeper,et al.  Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa , 2007, BMC pediatrics.

[3]  Antiretroviral therapy for children in the routine setting in Malawi. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  C. Yiannoutsos,et al.  Outcomes of HIV-Infected Orphaned and Non-Orphaned Children on Antiretroviral Therapy in Western Kenya , 2006, Journal of acquired immune deficiency syndromes.

[5]  C. Rouzioux,et al.  Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens , 2006, AIDS.

[6]  R. Zachariah,et al.  In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy , 2006, AIDS.

[7]  L. Palombi,et al.  Pediatric highly active antiretroviral therapy in Mozambique: an integrated model of care. , 2006, Minerva pediatrica.

[8]  B. Eley,et al.  Antiretroviral treatment for children. , 2006, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[9]  S. Gove,et al.  The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings , 2006, The Lancet.

[10]  Lesley E Scott,et al.  CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. , 2002, Cytometry.

[11]  R. de Groot,et al.  Efficacy of highly active antiretroviral therapy in HIV-1 infected children. , 2002, The Lancet. Infectious diseases.

[12]  P I Terasaki,et al.  Long-term survival. , 1988, Clinical transplants.